Novel cancer therapies for advanced cutaneous melanoma: The added value of radiomics in the decision...
Novel cancer therapies for advanced cutaneous melanoma: The added value of radiomics in the decision making process–A systematic review
About this item
Full title
Author / Creator
Publisher
United States: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Advanced malignant melanoma represents a public health matter due to its rising incidence and aggressiveness. Novel therapies such as immunotherapy are showing promising results with improved progression free and overall survival in melanoma patients. However, novel targeted and immunotherapies could generate atypical patterns of response which are...
Alternative Titles
Full title
Novel cancer therapies for advanced cutaneous melanoma: The added value of radiomics in the decision making process–A systematic review
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_701ac65c6f894042901c52aedb5ed154
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_701ac65c6f894042901c52aedb5ed154
Other Identifiers
ISSN
2045-7634
E-ISSN
2045-7634
DOI
10.1002/cam4.2709
